Dancing In The Bioprocessing Ballroom: Voices Of Experience

Single-use technology is well-established, and has made its way into commercial licensed facilities, but there is more innovation in this field that will further enhance its versatility into new markets and technologies. The closed-system ballroom manufacturing approach will enable biomanufacturers to take full advantage of the flexibility offered by single-use systems while driving out risk. It is particularly suitable for applications that require multiple or rapid changeovers and therapies with small-scale production.

Can A Shared Biomanufacturing Facility Be The Answer To The Demand Forecasting Dilemma?

Single-use technology has a critical role in the future of manufacturing, as it can eliminate costly and time-consuming cleaning and changeover costs and deliver more productive manufacturing times. Using a shared biomanufacturing facility, a biomanufacturer can minimize its investment while mitigating the risks of demand uncertainty and maximizing time-to-market.

Staying Flexible In Biomanufacturing

The concept of optionality is key to staying flexible in biomanufacturing by keeping your options open and having multiple pathways to take while navigating through this highly uncertain environment. Using a combination of financial options analysis and decision analytics to quantify your options helps to embrace the uncertainty equation.  

Evolution Of Single-Use Bioprocessing Into BioPharm 4.0

Biopharmaceutical manufacturers are seeking dynamic processing economics that address the paradigm shift from blockbuster drugs with established, large-batch production schemes to small-scale manufacturing and innovative technologies. By using data analytics, manufacturers can drive continuous improvements in efficiency.